• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Novartis

Novartis

Novartis AG ADR NVS 3 Star

Last Price$99.80Day Change (%)1.30%
Open Price$99.83Day Change ($)1.28
Day Range99.36–99.9752-Week Range84.17–105.82

As of Thu 7/2/2015 6:16:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Novartis Buys Drug Development Company Spinifex Pharmaceuticals

    Novartis Buys Drug Development Company Spinifex Pharmaceuticals

  2. Ergomed Appoints Andrew Mackie as Chief Business Officer

    Ergomed Appoints Andrew Mackie as Chief Business Officer

  3. ADRs End Higher; National Bank of Greece Rises

    ADRs End Higher; National Bank of Greece Rises

  4. Celgene to Pay Juno $1 Billion as Part of 10-Year Collaboration

    Celgene to Pay Juno $1 Billion as Part of 10-Year Collaboration

  5. Research and Markets: Partial Seizure - Pipeline Review, H1 2015

    Research and Markets: Partial Seizure - Pipeline Review, H1 2015

  6. Celgene to Pay Juno $1 Billion as Part of 10-Year Collaboration

    Celgene to Pay Juno $1 Billion as Part of 10-Year Collaboration

  7. Research and Markets: Global Travel Vaccines Market 2015-2019: With Janssen Pharmaceuticals, Pfizer and Novartis Dominating

    Research and Markets: Global Travel Vaccines Market 2015-2019: With Janssen Pharmaceuticals, Pfizer and Novartis Dominating

  8. ADRs End Higher; Telecom Italia Rises

    ADRs End Higher; Telecom Italia Rises

  9. Research and Markets: Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Research and Markets: Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

  10. Anacor Pharmaceuticals Announces Amendment to KERYDIN Commercialization Agreement

    Anacor Pharmaceuticals Announces Amendment to KERYDIN Commercialization Agreement

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.